Aristopharma Ltd

Our Products

Glucozid (Gliclazide)

Therapeutic Group : Antidiabetic

Share on facebook
Share on twitter
Share on print
Share on email
Gliclazide is a second-generation oral hypoglycemic sulfonylurea, which stimulates the release of insulin from pancreatic beta cells by facilitating Ca++ transport across the beta-cell membrane and decreases hepatic glucose output.